You just read:

First-in-Human Data Presented from Phase 1a Study of NKTR-358, a Novel T Regulatory Cell Stimulator, at Annual European Congress of Rheumatology

News provided by

Nektar Therapeutics

Jun 13, 2019, 06:45 ET